- Home
- ULH vs AUPH Comparison
ULH vs AUPH Comparison
Compare ULH & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- AUPH
- Stock Information
- Founded
- ULH 1932
- AUPH 1993
- Country
- ULH United States
- AUPH Canada
- Employees
- ULH N/A
- AUPH N/A
- Industry
- ULH Trucking Freight/Courier Services
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- ULH Industrials
- AUPH Health Care
- Exchange
- ULH Nasdaq
- AUPH Nasdaq
- Market Cap
- ULH 1.2B
- AUPH 1.0B
- IPO Year
- ULH 2005
- AUPH 1999
- Fundamental
- Price
- ULH $43.09
- AUPH $7.07
- Analyst Decision
- ULH Hold
- AUPH Strong Buy
- Analyst Count
- ULH 1
- AUPH 3
- Target Price
- ULH $46.00
- AUPH $10.33
- AVG Volume (30 Days)
- ULH 42.5K
- AUPH 845.4K
- Earning Date
- ULH 10-24-2024
- AUPH 10-31-2024
- Dividend Yield
- ULH 0.99%
- AUPH N/A
- EPS Growth
- ULH N/A
- AUPH N/A
- EPS
- ULH 4.85
- AUPH N/A
- Revenue
- ULH $1,766,241,000.00
- AUPH $207,105,000.00
- Revenue This Year
- ULH $12.63
- AUPH $36.05
- Revenue Next Year
- ULH N/A
- AUPH $18.87
- P/E Ratio
- ULH $8.77
- AUPH N/A
- Revenue Growth
- ULH N/A
- AUPH 29.35
- 52 Week Low
- ULH $20.85
- AUPH $4.71
- 52 Week High
- ULH $50.52
- AUPH $10.05
- Technical
- Relative Strength Index (RSI)
- ULH 45.77
- AUPH 52.23
- Support Level
- ULH $44.23
- AUPH $6.94
- Resistance Level
- ULH $45.87
- AUPH $7.33
- Average True Range (ATR)
- ULH 1.29
- AUPH 0.21
- MACD
- ULH -0.16
- AUPH -0.02
- Stochastic Oscillator
- ULH 21.75
- AUPH 62.77
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.